• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过细胞外蛋白酶清除 中的细胞外人类淀粉样 β 聚集物。

Removal of extracellular human amyloid beta aggregates by extracellular proteases in .

机构信息

Laboratory of Extracellular Matrix Regeneration, Institute of Translational Medicine, Department of Health Sciences and Technology, ETH Zürich, Schwerzenbach, Switzerland.

Center for Microscopy and Image Analysis, University of Zurich, Zurich, Switzerland.

出版信息

Elife. 2023 Sep 20;12:e83465. doi: 10.7554/eLife.83465.

DOI:10.7554/eLife.83465
PMID:37728486
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10541181/
Abstract

The amyloid beta (Aβ) plaques found in Alzheimer's disease (AD) patients' brains contain collagens and are embedded extracellularly. Several collagens have been proposed to influence Aβ aggregate formation, yet their role in clearance is unknown. To investigate the potential role of collagens in forming and clearance of extracellular aggregates in vivo, we created a transgenic strain that expresses and secretes human Aβ. This secreted Aβ forms aggregates in two distinct places within the extracellular matrix. In a screen for extracellular human Aβ aggregation regulators, we identified different collagens to ameliorate or potentiate Aβ aggregation. We show that a disintegrin and metalloprotease a disintegrin and metalloprotease 2 (ADM-2), an ortholog of ADAM9, reduces the load of extracellular Aβ aggregates. ADM-2 is required and sufficient to remove the extracellular Aβ aggregates. Thus, we provide in vivo evidence of collagens essential for aggregate formation and metalloprotease participating in extracellular Aβ aggregate removal.

摘要

阿尔茨海默病(AD)患者大脑中的淀粉样蛋白β(Aβ)斑块含有胶原蛋白,并且嵌入细胞外。已经提出了几种胶原蛋白来影响 Aβ 聚集物的形成,但它们在清除中的作用尚不清楚。为了研究胶原蛋白在体内形成和清除细胞外聚集物中的潜在作用,我们创建了一种表达和分泌人 Aβ的转基因品系。这种分泌的 Aβ 在细胞外基质的两个不同位置形成聚集物。在筛选细胞外人类 Aβ 聚集调节剂的过程中,我们发现不同的胶原蛋白可以改善或增强 Aβ 聚集。我们表明,一种解整合素和金属蛋白酶 2(ADM-2),ADAM9 的同源物,减少了细胞外 Aβ 聚集物的负荷。ADM-2 是必需且充分的,可以去除细胞外 Aβ 聚集物。因此,我们提供了体内证据表明胶原蛋白对于聚集物的形成是必需的,并且金属蛋白酶参与了细胞外 Aβ 聚集物的清除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/3dec8c453070/elife-83465-sa2-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/fdb19445939a/elife-83465-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/cdf13cde00c0/elife-83465-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/699210131d14/elife-83465-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/a24416ad924e/elife-83465-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/b45dc8b0f30a/elife-83465-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/1952cfd0139f/elife-83465-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/984c9468b31c/elife-83465-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/d618dfbfb747/elife-83465-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/64c0081b5d0f/elife-83465-fig2-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/1c19df236590/elife-83465-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/7d5b1bdef004/elife-83465-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/8009370d5607/elife-83465-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/428d3da1d84a/elife-83465-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/be361531463f/elife-83465-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/0bd6bc048aec/elife-83465-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/9910cfb32b15/elife-83465-fig4-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/fd9fa02fa66c/elife-83465-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/c6f45a101ad6/elife-83465-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/fefcbef99895/elife-83465-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/3c07776e39f6/elife-83465-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/9761ff5751fb/elife-83465-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/5bbaab3206ba/elife-83465-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/e8713fa82e61/elife-83465-sa2-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/e88e846e78bb/elife-83465-sa2-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/f34be3d6221b/elife-83465-sa2-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/ece77ee92c90/elife-83465-sa2-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/832039d923b8/elife-83465-sa2-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/970df446da25/elife-83465-sa2-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/62749287170f/elife-83465-sa2-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/df1be492c5b1/elife-83465-sa2-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/e8d9bb8210ff/elife-83465-sa2-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/7f2bee2b1aec/elife-83465-sa2-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/a90329747ce9/elife-83465-sa2-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/3dec8c453070/elife-83465-sa2-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/fdb19445939a/elife-83465-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/cdf13cde00c0/elife-83465-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/699210131d14/elife-83465-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/a24416ad924e/elife-83465-fig1-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/b45dc8b0f30a/elife-83465-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/1952cfd0139f/elife-83465-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/984c9468b31c/elife-83465-fig2-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/d618dfbfb747/elife-83465-fig2-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/64c0081b5d0f/elife-83465-fig2-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/1c19df236590/elife-83465-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/7d5b1bdef004/elife-83465-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/8009370d5607/elife-83465-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/428d3da1d84a/elife-83465-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/be361531463f/elife-83465-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/0bd6bc048aec/elife-83465-fig4-figsupp3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/9910cfb32b15/elife-83465-fig4-figsupp4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/fd9fa02fa66c/elife-83465-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/c6f45a101ad6/elife-83465-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/fefcbef99895/elife-83465-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/3c07776e39f6/elife-83465-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/9761ff5751fb/elife-83465-fig6-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/5bbaab3206ba/elife-83465-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/e8713fa82e61/elife-83465-sa2-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/e88e846e78bb/elife-83465-sa2-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/f34be3d6221b/elife-83465-sa2-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/ece77ee92c90/elife-83465-sa2-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/832039d923b8/elife-83465-sa2-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/970df446da25/elife-83465-sa2-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/62749287170f/elife-83465-sa2-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/df1be492c5b1/elife-83465-sa2-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/e8d9bb8210ff/elife-83465-sa2-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/7f2bee2b1aec/elife-83465-sa2-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/a90329747ce9/elife-83465-sa2-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b181/10541181/3dec8c453070/elife-83465-sa2-fig13.jpg

相似文献

1
Removal of extracellular human amyloid beta aggregates by extracellular proteases in .通过细胞外蛋白酶清除 中的细胞外人类淀粉样 β 聚集物。
Elife. 2023 Sep 20;12:e83465. doi: 10.7554/eLife.83465.
2
Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.阿尔茨海默病转基因小鼠模型中淀粉样斑块病变和相关 Aβ 肽聚集的化学成像。
J Neurochem. 2020 Mar;152(5):602-616. doi: 10.1111/jnc.14888. Epub 2019 Nov 6.
3
Clearance of extracellular human amyloid-β aggregates in by nutraceutical and pharmaceutical interventions.通过营养保健品和药物干预清除细胞外人类淀粉样β蛋白聚集体。
MicroPubl Biol. 2024 Jan 8;2024. doi: 10.17912/micropub.biology.000907. eCollection 2024.
4
Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.人淀粉样β肽和 tau 共表达可损害行为并导致秀丽隐杆线虫中特定基因表达的改变。
Neurobiol Dis. 2018 Jan;109(Pt A):88-101. doi: 10.1016/j.nbd.2017.10.003. Epub 2017 Oct 2.
5
Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.光遗传学淀粉样蛋白-β在神经退行性变中区分代谢和物理损伤的应用。
Elife. 2020 Mar 31;9:e52589. doi: 10.7554/eLife.52589.
6
Levels of Amyloid Beta () Expression in the Neurons Influence the Onset and Severity of Neuronally Mediated Phenotypes.淀粉样蛋白β () 在神经元中的表达水平影响神经元介导表型的发病和严重程度。
Cells. 2024 Sep 23;13(18):1598. doi: 10.3390/cells13181598.
7
Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain.β淀粉样蛋白(Aβ)1-40而非Aβ1-42促成了大鼠脑内阿尔茨海默病淀粉样原纤维的实验性形成。
J Neurosci. 1997 Nov 1;17(21):8187-93. doi: 10.1523/JNEUROSCI.17-21-08187.1997.
8
Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.淀粉样蛋白-βx-42(Aβx-42)的焦谷氨酸化,随后是 Aβ1-40 的沉积,是进行性阿尔茨海默病病理学中斑块多态性的基础。
J Biol Chem. 2019 Apr 26;294(17):6719-6732. doi: 10.1074/jbc.RA118.006604. Epub 2019 Feb 27.
9
Tetracycline and its analogues protect Caenorhabditis elegans from β amyloid-induced toxicity by targeting oligomers.四环素及其类似物通过靶向寡聚物保护秀丽隐杆线虫免受β淀粉样蛋白诱导的毒性。
Neurobiol Dis. 2010 Nov;40(2):424-31. doi: 10.1016/j.nbd.2010.07.002. Epub 2010 Jul 14.
10
A deuterohemin peptide protects a transgenic Caenorhabditis elegans model of Alzheimer's disease by inhibiting Aβ aggregation.一种二氢血红素肽通过抑制 Aβ 聚集来保护阿尔茨海默病的转基因秀丽隐杆线虫模型。
Bioorg Chem. 2019 Feb;82:332-339. doi: 10.1016/j.bioorg.2018.10.072. Epub 2018 Nov 3.

引用本文的文献

1
Inactivation of SIAH-1 E3 ligase attenuates Aβ toxicity by suppressing ubiquitin-dependent DVE-1 degradation in Caenorhabditis elegans models of Alzheimer's disease.在阿尔茨海默病的秀丽隐杆线虫模型中,SIAH-1 E3 连接酶的失活通过抑制泛素依赖性的 DVE-1 降解来减轻 Aβ 毒性。
J Biol Chem. 2025 May 9;301(6):110226. doi: 10.1016/j.jbc.2025.110226.
2
Loss of age-accumulated circRNAs ameliorate amyloid β-induced toxicity in a model for Alzheimer's disease.衰老积累的环状RNA的缺失可改善阿尔茨海默病模型中淀粉样β蛋白诱导的毒性。
Front Aging Neurosci. 2025 Mar 24;17:1464015. doi: 10.3389/fnagi.2025.1464015. eCollection 2025.
3

本文引用的文献

1
An unexpected role for the conserved ADAM-family metalloprotease ADM-2 in Caenorhabditis elegans molting.ADAM 家族金属蛋白酶 ADM-2 在秀丽隐杆线虫蜕皮中的作用出人意料。
PLoS Genet. 2022 May 31;18(5):e1010249. doi: 10.1371/journal.pgen.1010249. eCollection 2022 May.
2
Importance of CSF-based Aβ clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways.人类脑脊液中 Aβ 清除率随年龄增长的重要性随着血脑屏障/蛋白水解途径效能的下降而增加。
Commun Biol. 2022 Jan 27;5(1):98. doi: 10.1038/s42003-022-03037-0.
3
Basal lamina changes in neurodegenerative disorders.
Olfactory dysfunction as an early pathogenic indicator in models of Alzheimer's and polyglutamine diseases.
嗅觉功能障碍作为阿尔茨海默病和多聚谷氨酰胺疾病模型中的早期致病指标。
Front Aging Neurosci. 2024 Oct 1;16:1462238. doi: 10.3389/fnagi.2024.1462238. eCollection 2024.
4
Metabolic enzymes and as potential epigenetic regulators during embryogenesis.代谢酶以及在胚胎发育过程中作为潜在的表观遗传调节因子。
MicroPubl Biol. 2024 Jun 13;2024. doi: 10.17912/micropub.biology.001222. eCollection 2024.
5
Clearance of extracellular human amyloid-β aggregates in by nutraceutical and pharmaceutical interventions.通过营养保健品和药物干预清除细胞外人类淀粉样β蛋白聚集体。
MicroPubl Biol. 2024 Jan 8;2024. doi: 10.17912/micropub.biology.000907. eCollection 2024.
6
Towards Understanding Neurodegenerative Diseases: Insights from .从 中了解神经退行性疾病:见解 。
Int J Mol Sci. 2023 Dec 28;25(1):443. doi: 10.3390/ijms25010443.
基底膜在神经退行性疾病中的变化。
Mol Neurodegener. 2021 Dec 7;16(1):81. doi: 10.1186/s13024-021-00502-y.
4
Youthful and age-related matreotypes predict drugs promoting longevity.年轻和与年龄相关的基质模型预测促进长寿的药物。
Aging Cell. 2021 Sep;20(9):e13441. doi: 10.1111/acel.13441. Epub 2021 Aug 4.
5
Exercise Training-Induced Extracellular Matrix Protein Adaptation in Locomotor Muscles: A Systematic Review.运动训练诱导运动肌肉细胞外基质蛋白适应性:系统综述。
Cells. 2021 Apr 26;10(5):1022. doi: 10.3390/cells10051022.
6
Specific collagens maintain the cuticle permeability barrier in Caenorhabditis elegans.特定的胶原蛋白维持秀丽隐杆线虫表皮的通透性屏障。
Genetics. 2021 Mar 31;217(3). doi: 10.1093/genetics/iyaa047.
7
Exploring the conservation of Alzheimer-related pathways between H. sapiens and C. elegans: a network alignment approach.探讨人类和秀丽隐杆线虫之间与阿尔茨海默病相关通路的保守性:一种网络比对方法。
Sci Rep. 2021 Feb 25;11(1):4572. doi: 10.1038/s41598-021-83892-9.
8
The characterization of the matrisome and proposal of a novel collagen classification.基质体的表征及一种新型胶原蛋白分类法的提议。
Matrix Biol Plus. 2019 Feb 21;1:100001. doi: 10.1016/j.mbplus.2018.11.001. eCollection 2019 Feb.
9
Apoptotic neurons and amyloid-beta clearance by phagocytosis in Alzheimer's disease: Pathological mechanisms and therapeutic outlooks.阿尔茨海默病中凋亡神经元和淀粉样β的吞噬清除:病理机制与治疗展望。
Eur J Pharmacol. 2021 Mar 15;895:173873. doi: 10.1016/j.ejphar.2021.173873. Epub 2021 Jan 16.
10
Collagenous Alzheimer amyloid plaque component impacts on the compaction of amyloid-β plaques.胶原阿尔茨海默氏淀粉样斑块成分影响淀粉样-β斑块的致密化。
Acta Neuropathol Commun. 2020 Dec 7;8(1):212. doi: 10.1186/s40478-020-01075-5.